|
 | Biography |  |
Developing better methods for detection and critically examining new treatments to improve the management of patients with prostate cancer Early diagnosis of prostate cancer
I have pioneered the use of prostatic fluid in the early diagnosis of prostate cancer using ejaculate as the medium for study. With Professor Martin Lavin, this involves identifying and characterising markers and combining molecular profiling of disaggregated prostate cancer cells combined with other methods of analysis, in particular using metabonomics with Dr Horst Schirra. This work is designed to detect the presence of prostate cancer and, more importantly, characterise the nature of patients’ tumours.
Psychosocial Research
Having undertaken the only randomised, controlled trial to examine quality of life and cognitive effects of androgen deprivation therapy in prostate cancer with Associate Professor Ken Pakenham, I am involved in a comprehensive psychosocial research programme led by Professor Suzanne Chambers to improve the welfare of men diagnosed with and treated for prostate cancer and the welfare of their partners
Randomised study of open and robotic prostatectomy
With colleagues from the Northern Section of the Urological Society of Australia and New Zealand and collaborators from Griffiths and Deakin Universities and Peter MacCallum Cancer Centre, Professors Suzanne Chambers and Martin Lavin and Drs John Yaxley and Geoff Coughlin, we are undertaking the first randomised study of open and robotic prostatectomy to objectively establish the clinical and economic impacts of these treatments. We are also integrating our early diagnosis and psychosocial research into this trial and are committed to developing better methods for identifying significant competing morbidities, in particular cardiovascular disease, impacting on life expectancy of these men
|
» Contacts
